Singular Genomics Systems, Inc. (OMIC)
USD 19.6
(-0.56%)
USD 19.6
(-0.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -73.64 Million | -87.09 Million | -51.7 Million | -24.87 Million | -11.39 Million |
| Net Income | -94.82 Million | -90.87 Million | -98.77 Million | -27.94 Million | -12.32 Million |
| Depreciation & Amortization | 7.22 Million | 6.03 Million | 1.13 Million | 639 Thousand | 350 Thousand |
| Deferred income taxes | 782 Thousand | - | 4.13 Million | 281 Thousand | - |
| Stock-based compensation | 11.4 Million | 13.66 Million | 9.23 Million | 1.06 Million | 170 Thousand |
| Change in working capital | -2.24 Million | -16.81 Million | -2.91 Million | 858 Thousand | 415 Thousand |
| Other non-cash items | 4 Million | 901 Thousand | 35.47 Million | 234 Thousand | -10 Thousand |
| Investing Cash Flow | 13.8 Million | -39.56 Million | -130.86 Million | 24 Million | -31.5 Million |
| Investments in PPE | -970 Thousand | -6.02 Million | -4.86 Million | -1.38 Million | -800 Thousand |
| Acquisitions | - | 33.54 Million | 125.99 Million | -25.38 Million | 30.7 Million |
| Investment purchases | -183.59 Million | -174.71 Million | -195.68 Million | -6.07 Million | -42.72 Million |
| Sales/Maturities of investments | 198.37 Million | 141.16 Million | 69.68 Million | 31.46 Million | 12.02 Million |
| Other Investing Activities | - | -33.54 Million | -125.99 Million | 25.38 Million | -30.7 Million |
| Financing Cash Flow | 696 Thousand | 901 Thousand | 372.12 Million | 7.51 Million | 47.3 Million |
| Debt repayment | - | - | -10.4 Million | -7.5 Million | -2.46 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | -19 Thousand | -450 Thousand | 3.57 Million | -2000.00 | -21 Thousand |
| Common Stock Issuance | 13 Thousand | 1.35 Million | 240.77 Million | 17 Thousand | 41 Thousand |
| Other Financing Activities | 702 Thousand | 901 Thousand | 141.75 Million | 7.51 Million | 52.19 Million |
| Accounts receivables | 348 Thousand | -913 Thousand | - | - | - |
| Accounts payables | 267 Thousand | -1.16 Million | 1.85 Million | -148 Thousand | 244 Thousand |
| Inventory | -3.53 Million | -13.48 Million | - | - | - |
| Other working capital | 2.92 Million | -1.24 Million | -4.76 Million | 1 Million | 171 Thousand |
| Cash at beginning of period | 75.97 Million | 201.73 Million | 12.17 Million | 5.52 Million | 1.11 Million |
| Cash at end of period | 16.83 Million | 75.97 Million | 201.73 Million | 12.17 Million | 5.52 Million |
| Capital Expenditure | -970 Thousand | -6.02 Million | -4.86 Million | -1.38 Million | -800 Thousand |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -59.14 Million | -125.75 Million | 189.56 Million | 6.64 Million | 4.4 Million |
| Free Cash Flow | -74.61 Million | -93.11 Million | -56.56 Million | -26.25 Million | -12.19 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -21.25 Million | -25.02 Million | -94.82 Million | -23.24 Million | -22.36 Million | -25.57 Million |
| Depreciation & Amortization | 1.78 Million | 1.72 Million | 7.22 Million | 1.65 Million | 1.87 Million | 1.88 Million |
| Deferred income taxes | - | - | 782 Thousand | -1.07 Million | -1.1 Million | 1.63 Million |
| Stock-based compensation | 2.18 Million | 2.89 Million | 11.4 Million | 2.68 Million | 2.79 Million | 2.84 Million |
| Change in working capital | -548 Thousand | -2.58 Million | -2.24 Million | -981 Thousand | 110 Thousand | -810 Thousand |
| Other non-cash items | 6.24 Million | 6.54 Million | 4 Million | 2.05 Million | 1.87 Million | 33 Thousand |
| Investing Cash Flow | 23.96 Million | 31.57 Million | 13.8 Million | 651 Thousand | -24.7 Million | -35.08 Million |
| Investments in PPE | -1000.00 | -25 Thousand | -970 Thousand | -392 Thousand | -110 Thousand | -306 Thousand |
| Acquisitions | - | - | - | 38.32 Million | - | 34.78 Million |
| Investment purchases | -18.66 Million | -19.18 Million | -183.59 Million | -54.49 Million | -33.85 Million | -88.23 Million |
| Sales/Maturities of investments | 42.63 Million | 50.78 Million | 198.37 Million | 55.53 Million | 9.25 Million | 53.45 Million |
| Other Investing Activities | - | - | - | -38.32 Million | - | -34.78 Million |
| Financing Cash Flow | 80 Thousand | - | 696 Thousand | 72 Thousand | - | 618 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -19 Thousand | -6000.00 | - | -6000.00 |
| Common Stock Issuance | 80 Thousand | 26 Thousand | 13 Thousand | 78 Thousand | - | 624 Thousand |
| Other Financing Activities | 80 Thousand | - | 702 Thousand | -19 Thousand | - | 618 Thousand |
| Accounts receivables | -303 Thousand | 428 Thousand | 348 Thousand | -166 Thousand | -367 Thousand | -18 Thousand |
| Accounts payables | -127 Thousand | -28 Thousand | 267 Thousand | 1.58 Million | 180 Thousand | 287 Thousand |
| Inventory | -270 Thousand | -1.32 Million | -3.53 Million | -2.59 Million | -1.4 Million | -363 Thousand |
| Other working capital | 152 Thousand | -1.66 Million | 2.92 Million | 201 Thousand | 1.7 Million | -716 Thousand |
| Cash at beginning of period | 24.1 Million | 16.23 Million | 75.97 Million | 35.01 Million | 76.52 Million | 130.99 Million |
| Cash at end of period | 30.11 Million | 24.1 Million | 16.83 Million | 16.83 Million | 35.01 Million | 76.52 Million |
| Capital Expenditure | -1000.00 | -25 Thousand | -970 Thousand | -392 Thousand | -110 Thousand | -306 Thousand |
| Effect of forex changes on cash | - | - | - | -57.3 Million | - | 57.3 Million |
| Net cash flow / Change in cash | 6 Million | 7.87 Million | -59.14 Million | -18.17 Million | -41.51 Million | -54.46 Million |
| Free Cash Flow | -18.03 Million | -23.72 Million | -74.61 Million | -19.29 Million | -16.92 Million | -20.3 Million |
2183
601818
600284
KAEF
0288
CANDOUR